We would like to invite you to submit a paper or poster abstract for presentation at the
2023 PDA Parenteral Packaging Conference to take place on 18-19 April 2023.
Abstracts must be non-commercial in nature, describing new and innovative developments or work that significantly contributes to the body of knowledge relating to primary, secondary, and tertiary packaging of parenteral drugs and all related aspects as stated below.
The Scientific Program Planning Committee will review all proposals carefully and consider podium and poster contributions.
We look forward to receiving your topic proposal!
Bettine Boltres, WEST
Derek Duncan, LIGHTHOUSE
SCIENTIFIC PROGRAM PLANNING COMMITTEE:
- Bettine Boltres, WEST
- Derek Duncan, LIGHTHOUSE
- Ryan Forrey, BD
- Sinue Gomez, Corning
- Patricia Hughes, U.S. FDA
- Bram Jongen, Datwyler
- Arne Kloke, Alliance to Zero on behalf of SCHOTT Pharma
- Ankur Kulshrestha, Bristol-Myers Squibb
- Philippe Lauwers, Terumo
- Robert Ovadia, Gilead
- Coralie Richard, Eli Lilly & Company
- Folker Steden, SCHOTT
- Josh Eaton, PDA
- Falk Klar, PDA Europe
- Stefanie Nebelin, Manager Programs & Events, PDA Europe